Live Breaking News & Updates on Curevac

Stay informed with the latest breaking news from Curevac on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Curevac and stay connected to the pulse of your community

Here's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

How-well-is-curevac , Should-we-worry-about-curevac , Curevac , Ree-cash-flow ,

CureVac (NASDAQ:CVAC) Short Interest Down 11.6% in December

CureVac (NASDAQ:CVAC – Get Free Report) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 3,750,000 shares, a drop of 11.6% from the November 30th total of 4,240,000 shares. Currently, 4.1% of the shares of the company are sold short. Based on an […]

China , China-universal-asset-management-co , Cubist-systematic-strategies , Optiver-holding , Us-bancorp , Get-free-report , Vac-stock-down , Universal-asset-management , Curevac-daily , Curevac , Nasdaq-cvac

These Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts

One thing we could say about the analysts on CureVac N.V. ( NASDAQ:CVAC ) - they aren't optimistic, having just made a...

Curevac , Evenue-estimates , Arnings-per-share ,

CureVac (NASDAQ:CVAC) Hits New 12-Month Low at $3.41

CureVac (NASDAQ:CVAC – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $3.41 and last traded at $3.93, with a volume of 4123767 shares changing hands. The stock had previously closed at $5.82. CureVac Stock Down 3.4 % The business’s 50 day […]

Blackrock-inc , Citigroup-inc , Jpmorgan-chase-co , York-mellon-corp , Healthcare-of-ontario-pension-plan-trust-fund , Get-free-report , Vac-stock-down , New-york-mellon-corp , Ontario-pension-plan-trust-fund , Curevac-daily , Curevac

German court quashes CureVac patent after challenge by BioNTech

MUNICH (Reuters) -A German court on Tuesday invalidated a patent that was the basis of a patent violation lawsuit brought by CureVac against its domestic rival BioNTech, in a blow to CureVac's claims for a share in billions of euros in COVID-19 vaccine revenues. "The patent is being declared invalid for the territory of the Federal Republic of Germany," Walter Schramm, presiding judge in Germany's patent court, said in his ruling after a hearing. CureVac's Frankfurt-listed shares plunged 40% after the verdict.

Germany , Munich , Bayern , Federal-republic-of-germany , German , Walter-schramm , Hugh-lawson , Joern-poltz , Ludwig-burger , Pfizer , Reuters , Federal-republic

CureVac Shares Hit All-Time Low on German Patent Court Ruling

By Dean Seal Shares of CureVac fell to an all-time low after the company said a German federal court has denied the validity of an intellectual property...

Germany , German , German-federal-patent-court , Dean-seal , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Corporate-crime-legal-action , Patents

CureVac Tanks 25% After German Court Invalidates Patent Lawsuit Against BioNTech

Shares of CureVac N.V. (CVAC) tanked over 25% on Tuesday morning after a German court quashed a patent violation lawsuit brought by the company against rival BioNTech.

Germany , German , Federal-republic-of-germany , Walter-schramm , Alexander-zehnder , Nasdaq , German-federal-court , Federal-republic , Chief-executive-officer , Curevac ,

CureVac (NASDAQ:CVAC) Announces Quarterly Earnings Results

CureVac (NASDAQ:CVAC – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.24) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.02, reports. The company had revenue of $17.94 million for the quarter, compared to analyst estimates of $15.01 million. CureVac Stock Down 0.9 % […]

United-states , China , America , China-universal-asset-management-co , Cubist-systematic-strategies , Optiver-holding , Us-bancorp , Get-free-report , Vac-stock-down , Universal-asset-management , Curevac-daily

CureVac (NASDAQ:CVAC) Announces Earnings Results

CureVac (NASDAQ:CVAC – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.24) EPS for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.02, reports. The firm had revenue of $17.94 million for the quarter, compared to the consensus estimate of $15.01 million. CureVac Trading Down 0.9 % Shares of […]

United-states , America , Pricet-rowe-associates-inc , Blackrock-inc , Millennium-management , Curevac-company-profile , Alyeska-investment-group , Get-free-report , Vac-trading-down , Capital-management , Curevac-daily

CureVac N.V. (NASDAQ:CVAC) Q3 2023 Earnings Call Transcript

CureVac N.V. (NASDAQ:CVAC) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Greetings and welcome to the CureVac Financial Results for Third Quarter and First Nine Months of 2023 Business Update. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, […]

Panama , Virginia , United-states , Massachusetts , Germany , German , Alexander-zehnder , Pierre-kemula , Dusseldorf-court , Us-district-court , District-court , German-federal-patent-court